Laboratory testing for Zika virus infection
WHO Interim Guidance 2016 WHO/ZIKV/LAB/16.1.
This interim guidance is for use by staff of laboratories testing for Zika virus infection and for clinical practitioners and public health professionals providing clinical management or surveillance. The guidance is for the current testing strategies of Zika virus infection and the content includes: types of specimens, testing strategies, specimen processing and storage, biosafety, shipping specimens and choosing in vitro diagnostics.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.